Public issue of [*] equity shares of Rs. 10/- each of Advanced Enzyme Technologies Limited (The "Company" or the "Issuer") for cash at a price of per equity share (including a premium of per equity share) aggregating upto Rs. [*] crores (The "issue") comprising of a fresh issue of equity shares by our company aggregating to Rs. 200.00 crores (The "Fresh Issue") and an offer for sale upto 37,00,000 equity shares by Mr. Vasant Laxminarayan Rathi, Mr. Pradip Bhailal Shah, Chandrakant Rathi Finance and
Investment Company Private Limited, Mr. Madhusudan Kabraand, Mr. Kishor laxminarayan Rathi (The "selling shareholders") aggregating to Rs. [*] crores (The "offer for sale"). The issue comprises a reservation of upto 1,00,000 equity shares for subscription by eligible employees (The "Employee Reservation Portion"). The net issue will constitute 25% of the fully diluted post issue paid-up capital of the company.
Price Band: Rs. [*] to Rs. [*] per equity share of face value of Rs. 10/- each.
The floor price is [*] times of the face value and the cap price is [*] times of the face value.
|